- Presentations
- 2
- Markets
- 1
Rasonque is a brand of Daraxonrasib marketed by Revolution Medicines, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Daraxonrasib
- Brand owner
- Revolution Medicines
- Registered in
- United States
- Strengths and forms
- 100 mg tablet, 150 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Rasonque 100 mg tabletOral | Revolution Medicines | US FDA | Available on request |
| Rasonque 150 mg tabletOral | Revolution Medicines | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Rasonque
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.